JW-1601
- Generic Name
- JW-1601
A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People
Phase 1
Completed
- Conditions
- Healthy VolunteersCardiac Repolarisation
- Interventions
- First Posted Date
- 2022-08-19
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- JW Pharmaceutical
- Target Recruit Count
- 28
- Registration Number
- NCT05508776
- Locations
- 🇬🇧
LEO Investigational Site, Leeds, United Kingdom
Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
Phase 2
Completed
- Conditions
- Cholinergic Urticaria
- Interventions
- Drug: LEO 152020 placebo
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- JW Pharmaceutical
- Target Recruit Count
- 20
- Registration Number
- NCT04853992
- Locations
- 🇩🇪
LEO Investigational Site, München, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath